CN111065627A - 一种醇化合物的制备方法 - Google Patents

一种醇化合物的制备方法 Download PDF

Info

Publication number
CN111065627A
CN111065627A CN201880052089.2A CN201880052089A CN111065627A CN 111065627 A CN111065627 A CN 111065627A CN 201880052089 A CN201880052089 A CN 201880052089A CN 111065627 A CN111065627 A CN 111065627A
Authority
CN
China
Prior art keywords
reaction
formula
organic solvent
compound shown
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201880052089.2A
Other languages
English (en)
Other versions
CN111065627B (zh
Inventor
刘勇军
王仲清
廖守主
罗忠华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong HEC Pharmaceutical
Original Assignee
Dongguan Dongyangguang Medicine Research And Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Dongyangguang Medicine Research And Development Co ltd filed Critical Dongguan Dongyangguang Medicine Research And Development Co ltd
Publication of CN111065627A publication Critical patent/CN111065627A/zh
Application granted granted Critical
Publication of CN111065627B publication Critical patent/CN111065627B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

一种醇化合物的制备方法,通过原料胺化合物与酰卤化合物经过酰胺化反应,还原反应,酯化反应,和/或水解反应,获得目标产物。

Description

PCT国内申请,说明书已公开。

Claims (17)

  1. PCT国内申请,权利要求书已公开。
CN201880052089.2A 2017-08-17 2018-08-16 一种醇化合物的制备方法 Active CN111065627B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2017107059739 2017-08-17
CN201710705973 2017-08-17
PCT/CN2018/100730 WO2019034094A1 (zh) 2017-08-17 2018-08-16 一种醇化合物的制备方法

Publications (2)

Publication Number Publication Date
CN111065627A true CN111065627A (zh) 2020-04-24
CN111065627B CN111065627B (zh) 2023-03-28

Family

ID=65362743

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880052089.2A Active CN111065627B (zh) 2017-08-17 2018-08-16 一种醇化合物的制备方法

Country Status (2)

Country Link
CN (1) CN111065627B (zh)
WO (1) WO2019034094A1 (zh)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016034708A1 (de) * 2014-09-04 2016-03-10 Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet Verwendung eines quinoxalinderivats in einem bildgebenden verfahren
CN106279047A (zh) * 2015-05-13 2017-01-04 上海适济生物科技有限公司 一种前列环素受体激动剂的制备方法
CN106316967A (zh) * 2016-08-19 2017-01-11 上海艾康睿医药科技有限公司 西里帕格中间体及西里帕格的制备方法
WO2017029594A1 (en) * 2015-08-17 2017-02-23 Dr. Reddy's Laboratories Limited Processes for preparation of selexipag and its amorphous form
WO2017042828A2 (en) * 2015-09-10 2017-03-16 Megafine Pharma (P) Ltd. Process for the preparation of selexipag and intermediates thereof
WO2017060827A1 (en) * 2015-10-07 2017-04-13 Lupin Limited An imrpoved process for the preparation of selexipag or its pharmaceutically acceptable salts

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016034708A1 (de) * 2014-09-04 2016-03-10 Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet Verwendung eines quinoxalinderivats in einem bildgebenden verfahren
CN106279047A (zh) * 2015-05-13 2017-01-04 上海适济生物科技有限公司 一种前列环素受体激动剂的制备方法
WO2017029594A1 (en) * 2015-08-17 2017-02-23 Dr. Reddy's Laboratories Limited Processes for preparation of selexipag and its amorphous form
WO2017042828A2 (en) * 2015-09-10 2017-03-16 Megafine Pharma (P) Ltd. Process for the preparation of selexipag and intermediates thereof
WO2017060827A1 (en) * 2015-10-07 2017-04-13 Lupin Limited An imrpoved process for the preparation of selexipag or its pharmaceutically acceptable salts
CN106316967A (zh) * 2016-08-19 2017-01-11 上海艾康睿医药科技有限公司 西里帕格中间体及西里帕格的制备方法

Also Published As

Publication number Publication date
CN111065627B (zh) 2023-03-28
WO2019034094A1 (zh) 2019-02-21

Similar Documents

Publication Publication Date Title
CA2698245C (en) Process and intermediates for preparing integrase inhibitors
CN109563102A (zh) 生物素的中间体的制造方法、及生物素的制造方法
TW201429977A (zh) 於製備式i之吡啶并吡咯烯(pyripyropene)化合物之方法
EP2247572B1 (en) A one-pot process for preparing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
JP5646706B2 (ja) C−グリコシド誘導体の製造方法
JP7241682B2 (ja) 重水素化イミダゾリジンジオン系化合物を調製する方法
CN111065627B (zh) 一种醇化合物的制备方法
CN111170893A (zh) Lefamulin的中间体化合物及其在Lefamulin制备中的应用
CN111072450B (zh) 一种烯丙醇类衍生物的合成方法
CN114163380B (zh) 阿伐可泮中间体及其制备方法和用途
JP2013234126A (ja) メルカプト化合物
CN110551123A (zh) 一种5-(叔丁氧羰基)-2-甲基-4,5,6,7-四氢-2h-吡唑并[4,3-c]吡啶-7-羧酸的制备方法
EP4130020A1 (en) Novel method for preparing inotodiol
JP6676146B2 (ja) クロマノール誘導体の新規な製造方法
CN113024375B (zh) 一种反,反-4-烷基-4′-戊基-3(e)烯-双环己烷类液晶单体的制备方法
CN110577490B (zh) 阿维巴坦中间体(2s,5s)-n-保护基-5-羟基-2-甲酸哌啶的合成方法
JP6963435B2 (ja) ビオチンの中間体の製造方法、およびビオチンの製造方法
CN109265408B (zh) 二氟甲基取代噁烷-2-酮的合成方法
CN108239040B (zh) 硝酸2-(4-甲基噻唑-5-基)乙酯盐酸盐的制备方法
CN111362989A (zh) 一种索非布韦关键中间体的制备方法
CN111217709A (zh) 一种(1-氟环丙基)甲胺盐酸盐的制备方法
KR102436114B1 (ko) 신규한 이노토디올의 제조방법
CN105237606B (zh) 一种用于合成去氧孕烯的中间体及其制备方法和应用
KR102418153B1 (ko) 신규한 이노토디올의 제조방법
CN111039963B (zh) Wxfl10203614水溶性类似物及其合成方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20221229

Address after: 523808 No.1, Gongye North Road, Songshanhu Park, Dongguan City, Guangdong Province

Applicant after: SUNSHINE LAKE PHARMA Co.,Ltd.

Address before: 368 Zhen'an Middle Road, Chang'an Town, Dongguan City, Guangdong Province

Applicant before: DONGGUAN HEC PHARM R&D Co.,Ltd.

GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 523808 No.1, Gongye North Road, Songshanhu Park, Dongguan City, Guangdong Province

Patentee after: Guangdong Dongyangguang Pharmaceutical Co.,Ltd.

Address before: 523808 No.1, Gongye North Road, Songshanhu Park, Dongguan City, Guangdong Province

Patentee before: SUNSHINE LAKE PHARMA Co.,Ltd.